Manuel Molina
University of Miami
34 Papers
78 Citations
Manuel Molina is an academic researcher from University of Miami. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 8, co-authored 15 publications.
Chat about Author
Papers
African American and poor patients have a dramatically worse prognosis for head and neck cancer: an examination of 20,915 patients.
Manuel Molina,Michael C. Cheung,Eduardo A. Perez,Margaret M. Byrne,Dido Franceschi,Frederick L. Moffat,Alan S. Livingstone,W. Jarrard Goodwin,Juan C. Gutierrez,Leonidas G. Koniaris +9 more
TL;DR: To identify points of intervention and improve survival, the authors sought to determine the impact of race, ethnicity, and socioeconomic status for patients with cancers of the head and neck (HN).
202
Impact of Hospital Volume on Surgical Outcome for Head and Neck Cancer
Michael C. Cheung,Leonidas G. Koniaris,Eduardo A. Perez,Manuel Molina,W. Jarred Goodwin,Rabih M. Salloum +5 more
TL;DR: It is concluded that HNC patients treated at a high-volume center have significantly better long-term survival and cure rates.
95
Breast Specimen Orientation
Manuel Molina,Sarah E. Snell,Dido Franceschi,M. Jorda,C. Gomez,Fredrick Moffat,J. Powell,Eli Avisar +7 more
TL;DR: Assessment of the correlation in orientation between surgeons and pathologists found better orientation techniques are necessary to minimize the specimen disorientation.
54
Effect of Natesto on Reproductive Hormones, Semen Parameters and Hypogonadal Symptoms: A Single Center, Open Label, Single Arm Trial
Ranjith Ramasamy,Thomas A. Masterson,Jordan C. Best,Joshua Bitran,Emad Ibrahim,Manuel Molina,Ursula B. Kaiser,Feng Miao,Isildinha M. Reis +8 more
TL;DR: Natesto appears to increase testosterone while maintaining semen parameters in a majority of men, and has the potential to be a safe and effective treatment for men with functional hypogonadism who wish to preserve semen parameters.
44
Natesto Effects on Reproductive Hormones and Semen Parameters: Results from an Ongoing Single-center, Investigator-initiated Phase IV Clinical Trial.
TL;DR: Promising initial data from a perspective clinical trial demonstrates that Natesto can not only increase serum testosterone but also maintain follicle-stimulating hormone, luteinizing hormone, and importantly, semen parameters.
26